Press release
Antihypertensive Drugs Market | Size, Growth, Trends and Analysis 2022-2027
Antihypertensive Drugs Market
Antihypertensive drugs refer to therapeutic medications that are used to prevent, control, and treat hypertension and high blood pressure problems. They include diuretics, angiotensin-converting enzyme inhibitors, vasodilators, beta-blockers, calcium channel blockers, etc. Antihypertensive drugs assist in removing excess fluids and salts and in relaxing and broadening the blood vessels. They also aid in maintaining healthy systolic blood pressure by slowing down the heartbeat and can be given orally or through intravenous injections. Consequently, antihypertensive drugs are widely utilized in hospitals, clinics, rehabilitation facilities, ambulatory surgery centers, etc., across the globe.
Request Free Sample Report:
https://www.imarcgroup.com/antihypertensive-drugs-market/requestsample
Market Trends:
The increasing prevalence of cardiovascular disorders and hypertension is among the primary factors augmenting the antihypertensive drugs market. Moreover, the expanding geriatric population, who are more prone to numerous heart illnesses, is further propelling the market growth. Apart from this, the elevating number of patients suffering from hypertension and high blood pressure, owing to the sedentary lifestyles and unhealthy dietary patterns of individuals, is acting as another significant growth-inducing factor. Furthermore, the launch of imidazolines, monatepil, and neutral endopeptidase inhibitors is also positively influencing the global market for antihypertensive drugs. In addition to this, the inflating healthcare expenditures and the extensive research and development (R&D) activities are projected to catalyze the antihypertensive drugs market over the forecasted period.
Browse Full Report With TOC: https://www.imarcgroup.com/antihypertensive-drugs-market
Key Market Segmentation:
Some of these key players include:
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Company Limited
• Johnson & Johnson Services Inc.
• Lupin Pharmaceuticals Inc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi and Sun Pharmaceutical Industries Ltd.
Breakup by Therapeutic Class:
• Diuretics
• ACE Inhibitors
• Calcium Channel Blockers
• Beta-adrenergic Blockers
• Vasodilators
• Others
Breakup by Type:
• Primary hypertension
• Secondary Hypertension
Breakup by Distribution Channel:
• Retail Pharmacy
• Hospital Pharmacy
• E-Commerce
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antihypertensive Drugs Market | Size, Growth, Trends and Analysis 2022-2027 here
News-ID: 2916239 • Views: …
More Releases from IMARC Group
Australia Advanced Carbon Dioxide Sensors Market | Worth USD 103.89 Million 2026 …
Market Overview
The Australia advanced carbon dioxide sensors market size was USD 59.19 Million in 2025 and is expected to grow to USD 103.89 Million by 2034. The market growth is driven by strong government-led emissions reduction policies, enhanced building standards for CO2 monitoring, and the integration of IoT-enabled sensor technologies in smart buildings. These trends are supported by increased focus on indoor air quality and workplace health, fueling innovation in…
Australia Used Car Market Projected to Reach USD 197 Billion by 2033
Market Overview
The Australia used car market was valued at USD 77.2 Billion in 2024 and is projected to reach USD 197 Billion by 2033. The market is experiencing strong growth driven by affordability concerns, rising demand for reliable pre-owned vehicles, and the increasing role of digital platforms that simplify transactions. Economic pressures and the shift toward cost-effective vehicle options are further accelerating expansion, making the used car market a vital…
Australia Electric Truck Market Projected to Reach USD 133.0 Million by 2033
Market Overview
The Australia electric truck market reached USD 17.1 Million in 2024 and is projected to expand to USD 133.0 Million by 2033. With a forecast period spanning 2025 to 2033, the market is growing significantly due to stringent government emissions regulations, rising fuel costs, and advancements in battery and charging infrastructure technologies. Investments in fleet electrification and sustainable transport solutions are further driving market share growth. For further details,…
Australia Wealth Management Market Projected to Reach USD 213.2 Million by 2033
Market Overview
The Australia Wealth Management Market reached a size of USD 110.3 Million in 2024 and is projected to grow to USD 213.2 Million by 2033. The market is expected to expand during its forecast period with a CAGR of 7.60% from 2025 to 2033. Key growth factors include rising high-net-worth individuals, digital financial transformation, regulatory reforms like FOFA, and a robust superannuation system. For more details, visit the Australia…
More Releases for Antihypertensive
Antihypertensive Drugs Market Future Prediction Report By 2033
The global Antihypertensive Drugs Market was valued at approximately USD 30.5 billion in 2024 and is projected to reach around USD 38.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2033 .
Antihypertensive Drugs Market Overview
The global Antihypertensive Drugs Marke is driven by the rising global burden of hypertension, especially among the elderly and individuals with lifestyle-related risk factors such as obesity, poor…
Antihypertensive Drugs Market Segmentation, and Future Growth Prospects
In recent years, the global Antihypertensive Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Antihypertensive Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Antihypertensive Drugs Market Size to Reach USD 10 Billion 2030
Exclusive Report by Ameco Research: Antihypertensive Drugs Market Size Projected to Reach USD 52 Billion by 2030, Growing at 4.70% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Antihypertensive Drugs Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Antihypertensive Drugs Market to Develop Rapidly by 2031, TMR Study
The global Antihypertensive Drugs Market market is estimated to attain a valuation of US$ 40 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3% during the forecast period, 2022 to 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ev …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis…
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best…
